Dr. Lyon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Burlington, VT 05401Phone+1 802-847-4237
Education & Training
- University of Vermont Medical CenterResidency, Internal Medicine, 2002 - 2005
- University of Vermont College of MedicineClass of 2002
Certifications & Licensure
- VT State Medical License 2006 - 2026
Clinical Trials
- Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Start of enrollment: 2010 Jan 01
- A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047 Start of enrollment: 2017 May 01
Publications & Presentations
PubMed
- A site assessment tool for inpatient controlled human infection models for enteric disease pathogens.Chad K. Porter, Katherine J Detizio, Nicole Maier, Kayla J. Testa, Kawsar R. Talaat
Clinical Trials. 2021-10-28 - 11 citationsImmune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 InabaMotaher Hossain, Kamrul Islam, Meagan Kelly, Leslie M. Mayo Smith, Richelle C. Charles
Plos Neglected Tropical Diseases. 2019-11-19 - 20 citationsLipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.Douglas Haney, Michael Lock, Marc Gurwith, Jakub K. Simon, Glenn Ishioka
Vaccine. 2018-05-11
Press Mentions
- UVM Researchers Test First-Ever Cholera VaccineJune 15th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: